• Profile
Close

Clinical validity of DSM-5 attenuated psychosis syndrome: Advances in diagnosis, prognosis, and treatment

JAMA Psychiatry Dec 11, 2019

de Pablo GS, et al. - Researchers investigated the clinical validity of DSM-5 attenuated psychosis syndrome (DSM-5–APS), focusing on recent advances in diagnosis, prognosis, and treatment. They conducted a systematic review including 56 articles and meta-analysis including 23 cohort studies. They tested the clinical validity of DSM-5–APS against evidence-based antecedent, concurrent, and prognostic validators. Association of DSM-5–APS criteria with frequent depressive comorbid disorders, distress, suicidality, and functional impairment was reported. DSM-5–APS has received substantial concurrent and prognostic validation; psychometric research in the field of the clinical high-risk state for psychosis provided most of the validation. However, the available works lack investigation regarding precipitating and predisposing epidemiological factors, neurobiological research, and treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay